Dried blood spot UHPLC-MS/MS analysis of oseltamivir and oseltamivircarboxylate--a validated assay for the clinic.
about
Prolonged influenza virus shedding and emergence of antiviral resistance in immunocompromised patients and ferretsAdvantages and Challenges of Dried Blood Spot Analysis by Mass Spectrometry Across the Total Testing ProcessImpact of internal standard addition on dried blood spot analysis in bioanalytical method development.Simple and sensitive assay for quantification of oseltamivir and its active metabolite oseltamivir carboxylate in human plasma using high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry: improved appliState-of-the-art dried blood spot analysis: an overview of recent advances and future trends.Dried blood spots: concepts, present status, and future perspectives in bioanalysis.The use of mass spectrometry to analyze dried blood spots.Procedures and practices for the validation of bioanalytical methods using dried blood spots: a review.Clinical perspectives of dried blood spot protein quantification using mass spectrometry methods.Heat stabilization of blood spot samples for determination of metabolically unstable drug compounds.Assessment of the within- and between-lot variability of Whatman™ FTA(®) DMPK and 903(®) DBS papers and their suitability for the quantitative bioanalysis of small molecules.Rapid LC-MS/MS quantification of the major benzodiazepines and their metabolites on dried blood spots using a simple and cost-effective sample pretreatment.Evaluation of peripheral blood microsampling techniques in combination with liquid chromatography-high resolution mass spectrometry for the determination of drug pharmacokinetics in clinical studies.
P2860
Q27334946-A5318FA4-9AE8-4C2D-A48E-A8A4BBB19DCFQ29109543-E602F7A0-40CB-4BAE-8AD1-68FCDE4EE118Q34051573-2DBA7897-3ADB-4809-BBD6-B1556B02BD27Q36395220-A91C7C9F-E631-4F3B-83DB-77D151A73E35Q38130332-7022CBDE-FFC8-4A70-B58F-05FBA53BD20EQ38201371-A467B4D5-6BE2-4457-B297-F10B74952A11Q38253959-A4D42F67-4638-44F9-8D06-7E977A175727Q38266632-1F1EB893-4D72-4984-8F41-D9F9F992F01AQ39231107-9B6E4C81-D323-4BF8-ABC2-1B8FEC13B28CQ39700814-736F1549-AAFF-4F75-9A86-F82DE0DCED14Q50469847-6C18BA5C-01D4-46CD-8C77-F28D2F90F9ACQ53128171-E7F976E9-BD2E-49B9-812F-75E6AAA8E54BQ54562543-9C53B09D-C491-4F5D-8237-EAB3130188FC
P2860
Dried blood spot UHPLC-MS/MS analysis of oseltamivir and oseltamivircarboxylate--a validated assay for the clinic.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Dried blood spot UHPLC-MS/MS a ...... alidated assay for the clinic.
@ast
Dried blood spot UHPLC-MS/MS a ...... alidated assay for the clinic.
@en
type
label
Dried blood spot UHPLC-MS/MS a ...... alidated assay for the clinic.
@ast
Dried blood spot UHPLC-MS/MS a ...... alidated assay for the clinic.
@en
prefLabel
Dried blood spot UHPLC-MS/MS a ...... alidated assay for the clinic.
@ast
Dried blood spot UHPLC-MS/MS a ...... alidated assay for the clinic.
@en
P2093
P2860
P50
P1476
Dried blood spot UHPLC-MS/MS a ...... validated assay for the clinic
@en
P2093
Asmar F Y Al Hadithy
Gero P Hooff
Jeroen J A van Kampen
Teun van Gelder
Theo M Luider
P2860
P2888
P304
P356
10.1007/S00216-011-5050-Z
P407
P577
2011-05-03T00:00:00Z